NCT00346814View on ClinicalTrials.gov

Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome

PHASE2/PHASE3RecruitingINTERVENTIONAL
Timeline

Start Date

July 31, 2007

Primary Completion Date

July 31, 2007

Study Completion Date

November 30, 2024

Conditions
Retinopathy of Prematurity
Interventions
DRUG

intravitreal injection

Trial Locations (1)

04030

RECRUITING

"Asociación para Evitar la Ceguera en México Hospital Luis Sanchez Bulnes", Mexico City

All Listed Sponsors
lead

Asociación para Evitar la Ceguera en México

OTHER

NCT00346814 - Antiangiogenic Therapy With Bevacizumab in Retinopathy of Prematurity. Structural Outcome | Biotech Hunter | Biotech Hunter